Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium.

[1]  W. Maughan,et al.  Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. , 2000, Clinical chemistry.

[2]  G J Kost,et al.  Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. , 2000, Archives of pathology & laboratory medicine.

[3]  C. Price,et al.  Laboratory medicine in the United Kingdom: 1948-1998 and beyond. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[4]  D. Mutrie.  A new chest pain strategy in Thunder Bay. , 1999, CJEM.

[5]  G J Kost,et al.  The laboratory-clinical interface: point-of-care testing. , 1999, Chest.

[6]  I. Watson,et al.  Point-of-care testing outcomes in an emergency department. , 1999, Clinical chemistry.

[7]  M. Clancy,et al.  The Portable Laboratory: An Evaluation of the Accuracy and Reproducibility of i-STAT© , 1999, Annals of clinical biochemistry.

[8]  R. Califf,et al.  Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1998, American heart journal.

[9]  S. Griffin,et al.  Diabetes care in general practice: meta-analysis of randomised control trials. , 1998, BMJ.

[10]  S J Steindel,et al.  Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. , 1998, Clinical chemistry.

[11]  M. Clancy,et al.  Point of care testing: randomised controlled trial of clinical outcome , 1998, BMJ.

[12]  D. Fitzmaurice,et al.  A review of near patient testing in primary care. , 1997, Health technology assessment.

[13]  T. Zerbe,et al.  Laboratory process improvement through point-of-care testing. , 1997, The Joint Commission journal on quality improvement.

[14]  R. Jones,et al.  An evaluation of near‐patient testing for Helicobacter pylori in general practice , 1997, Alimentary pharmacology & therapeutics.

[15]  C A Parvin,et al.  Impact of point-of-care testing on patients' length of stay in a large emergency department. , 1996, Clinical chemistry.

[16]  J. Dunbar,et al.  Evaluation of a primary care anticoagulant clinic managed by a pharmacist , 1996, BMJ.

[17]  B. Bain,et al.  Guide-lines for near patient testing: haematology. , 1995, Clinical and laboratory haematology.

[18]  K. Lewandrowski,et al.  Near patient blood glucose monitoring. , 1995, Archives of pathology & laboratory medicine.

[19]  M Fleisher,et al.  Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing. , 1995, American journal of clinical pathology.

[20]  P. H. Petersen,et al.  Desirable performance standards for imprecision and bias in alternate sites. The views of laboratory professionals. , 1995, Archives of pathology & laboratory medicine.

[21]  R. Winkens,et al.  The validity of urine examination for urinary tract infections in daily practice. , 1995, Family practice.

[22]  A. Dixon,et al.  Measuring the effects of imaging: an evaluative framework. , 1995, Clinical radiology.

[23]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[24]  M F Burritt,et al.  Point-of-care testing. , 1995, Mayo Clinic proceedings.

[25]  P. Auerbach,et al.  Evaluation of a portable clinical blood analyzer in the emergency department. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[26]  J. Nosanchuk,et al.  Cost analysis of point-of-care laboratory testing in a community hospital. , 1995, American journal of clinical pathology.

[27]  G S Cembrowski,et al.  Patient and physician analytic goals for self-monitoring blood glucose instruments. , 1994, American journal of clinical pathology.

[28]  J W Winkelman,et al.  The fiscal consequences of central vs distributed testing of glucose. , 1994, Clinical chemistry.

[29]  J. Winkelman,et al.  Quantification of medical and operational factors determining central versus satellite laboratory testing of blood gases. , 1994, American journal of clinical pathology.

[30]  M. Berkus,et al.  Intensified versus conventional management of gestational diabetes. , 1994, American journal of obstetrics and gynecology.

[31]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[32]  B. Sibbald,et al.  Impact of introducing near patient testing for standard investigations in general practice. , 1993, BMJ.

[33]  M. Berkus,et al.  Glucose Tolerance Test: Degree of Glucose Abnormality Correlates With Neonatal Outcome , 1993, Obstetrics and gynecology.

[34]  C P Price,et al.  Extra‐laboratory Blood Glucose Measurement: A Policy Statement , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[35]  T. Koschinsky,et al.  New Approach to Technical and Clinical Evaluation of Devices for Self-Monitoring of Blood Glucose , 1988, Diabetes Care.

[36]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[37]  S. Kalhan,et al.  Gestational Diabetes Mellitus: Is Further Improvement Necessary? , 1985, Diabetes.

[38]  W. Oh,et al.  Neonatal Morbidities in Infants of Mothers with Glucose Intolerance in Pregnancy , 1985, Diabetes.

[39]  J. Skyler,et al.  Self-monitoring of blood glucose. , 1982, The Medical clinics of North America.

[40]  G J Kost,et al.  Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. , 2000, American journal of clinical pathology.

[41]  P. Collinson,et al.  The need for a point of care testing: an evidence-based appraisal. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[42]  R. Hendel,et al.  A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. , 1999, American heart journal.

[43]  C. Price.  Point of Care Testing in Haematology. , 1998, Hematology.

[44]  D. Benjamin.  Editorial: Reengineering the Clinical Laboratory , 1997 .

[45]  M. A. Smith,et al.  Health technology assessment and the NHS R&D initiative. , 1996, Journal of medical engineering & technology.

[46]  B. Kasiske,et al.  Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  E. Spitznagel,et al.  Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.

[48]  J. Hall,et al.  A ROLE FOR COMMUNITY PHARMACISTS IN THE CONTROL OF ANTICOAGULANT THERAPY , 1994 .

[49]  R. M. Greendyke.  Cost analysis. Bedside blood glucose testing. , 1992, American journal of clinical pathology.

[50]  Rainer Haeckel,et al.  Cost Implications of Decentralized Testing — A Laboratorian’s View , 1987 .

[51]  J. Ashby.  The Patient and Decentralized Testing , 1987 .

[52]  C. Ward,et al.  The Patient with Chest Pain , 1981 .